Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8647324 | Multiple Sclerosis and Related Disorders | 2018 | 17 Pages |
Abstract
This survey uncovered a low level of knowledge about DMTs' teratogenic risks among MS patients irrespective of sex. Knowledge about potential teratogenic risks for male MS patients receiving DMTs while planning to start a family was largely absent. 10% of female patients had experienced unplanned pregnancies on MS treatment. In general, patients use the internet and their neurologist to the same extent for information on parenthood planning.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Peter Vestergaard Rasmussen, Melinda Magyari, Julie Yoon Moberg, Mette Bøgelund, Ulla Fie Appel Jensen, Klaus Gregaard Madsen,